Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
87.34
Dollar change
-1.27
Percentage change
-1.43
%
Index- P/E100.25 EPS (ttm)0.87 Insider Own2.04% Shs Outstand188.60M Perf Week3.84%
Market Cap16.48B Forward P/E32.53 EPS next Y2.68 Insider Trans-2.93% Shs Float184.83M Perf Month-1.20%
Income167.65M PEG2.33 EPS next Q0.33 Inst Own99.28% Short Float1.60% Perf Quarter-10.77%
Sales2.42B P/S6.81 EPS this Y81.99% Inst Trans2.04% Short Ratio2.26 Perf Half Y-3.35%
Book/sh26.25 P/B3.33 EPS next Y69.57% ROA2.54% Short Interest2.96M Perf Year-4.48%
Cash/sh5.69 P/C15.35 EPS next 5Y43.00% ROE3.51% 52W Range76.02 - 100.38 Perf YTD-9.42%
Dividend Est.- P/FCF263.37 EPS past 5Y- ROI3.00% 52W High-12.99% Beta0.31
Dividend TTM- Quick Ratio1.57 Sales past 5Y10.23% Gross Margin76.15% 52W Low14.89% ATR (14)1.73
Dividend Ex-Date- Current Ratio2.51 EPS Y/Y TTM16.20% Oper. Margin8.01% RSI (14)52.33 Volatility1.84% 1.91%
Employees3401 Debt/Eq0.23 Sales Y/Y TTM18.16% Profit Margin6.93% Recom1.76 Target Price109.52
Option/ShortYes / Yes LT Debt/Eq0.13 EPS Q/Q8269.23% Payout0.00% Rel Volume0.75 Prev Close88.61
Sales Surprise1.16% EPS Surprise-43.73% Sales Q/Q25.23% EarningsFeb 22 AMC Avg Volume1.31M Price87.34
SMA201.80% SMA50-0.99% SMA200-2.19% Trades Volume977,724 Change-1.43%
Date Action Analyst Rating Change Price Target Change
Nov-15-23Initiated Wells Fargo Overweight $100
Oct-23-23Upgrade Bernstein Underperform → Mkt Perform $82
Sep-28-23Initiated Raymond James Mkt Perform
Sep-18-23Initiated UBS Buy $120
Jul-27-23Initiated Scotiabank Sector Perform $95
Jul-05-23Upgrade BMO Capital Markets Market Perform → Outperform $102
Jun-14-23Resumed Credit Suisse Outperform $120
Mar-21-23Initiated Bernstein Underperform $81
Feb-22-23Downgrade Oppenheimer Outperform → Perform
Feb-21-23Initiated Citigroup Neutral $116
Mar-17-24 08:50AM
Mar-16-24 05:06AM
Mar-12-24 08:30AM
Mar-11-24 10:00AM
Mar-08-24 01:31AM
08:30AM Loading…
Mar-07-24 08:30AM
Mar-01-24 09:00AM
Feb-27-24 12:03AM
Feb-26-24 02:36PM
02:12PM
Feb-23-24 04:29PM
12:33PM
11:34AM
07:21AM
05:43AM
04:25AM Loading…
04:25AM
Feb-22-24 06:00PM
05:15PM
04:42PM
04:23PM
04:03PM
Feb-19-24 09:15AM
Feb-15-24 10:00AM
Feb-13-24 01:10PM
Feb-08-24 04:10PM
08:00AM
Feb-07-24 05:21AM
Feb-06-24 08:30AM
Jan-24-24 11:21AM
Jan-23-24 08:00AM
05:06AM Loading…
Jan-20-24 05:06AM
Jan-15-24 09:45AM
Jan-10-24 06:16PM
Jan-03-24 08:00AM
Dec-21-23 06:14AM
Dec-20-23 05:08PM
04:05PM
Dec-14-23 07:05PM
Dec-05-23 11:01AM
Dec-02-23 05:06AM
Dec-01-23 11:31AM
Nov-29-23 09:13PM
06:30AM
Nov-28-23 11:09AM
08:30AM
Nov-16-23 08:47AM
Nov-10-23 12:58AM
Nov-09-23 04:43PM
03:49AM
Nov-08-23 05:19AM
Nov-07-23 07:09PM
05:07PM
02:24PM
Nov-06-23 07:20PM
Nov-04-23 05:06AM
Nov-03-23 01:23AM
Nov-02-23 05:02PM
12:17PM
08:44AM
07:15AM
Nov-01-23 06:30PM
05:55PM
05:02PM
04:05PM
04:02PM
Oct-27-23 07:15AM
Oct-26-23 11:28AM
10:02AM
Oct-25-23 10:02AM
Oct-23-23 09:50AM
Oct-20-23 04:20PM
04:11PM
04:05PM
Oct-19-23 12:17PM
08:15AM
Oct-18-23 12:10PM
Oct-17-23 08:30AM
Sep-23-23 05:06AM
Sep-21-23 10:00AM
Sep-18-23 10:52AM
09:55AM
Sep-15-23 12:50PM
09:29AM
08:37AM
Sep-11-23 08:30AM
Sep-06-23 08:30AM
Sep-05-23 08:30AM
Sep-02-23 05:06AM
Sep-01-23 11:31AM
Aug-31-23 11:31AM
Aug-30-23 04:05PM
Aug-12-23 05:06AM
Aug-01-23 01:37PM
12:35PM
12:06PM
Jul-31-23 07:30PM
05:35PM
04:29PM
04:03PM
Jul-27-23 09:56AM
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Slamon DennisDirectorMar 18 '24Option Exercise79.7010,000797,00040,809Mar 20 05:13 PM
BIENAIME JEAN JACQUESDirectorMar 06 '24Sale86.711,00086,713560,203Mar 07 05:35 PM
FUCHS HENRY JPresident, Worldwide R&DMar 05 '24Sale85.1835,3413,010,396212,117Mar 07 06:54 PM
Ajer Jeffrey RobertEVP, Chief Commercial OfficerMar 05 '24Sale87.074,000348,28094,047Mar 07 05:32 PM
BIENAIME JEAN JACQUESDirectorMar 05 '24Sale85.511,00085,510561,203Mar 07 05:35 PM
BIENAIME JEAN JACQUESDirectorFeb 27 '24Sale90.351,00090,350562,203Feb 29 05:05 PM
BIENAIME JEAN JACQUESDirectorFeb 09 '24Option Exercise63.1015,000946,500434,602Feb 12 05:20 PM
BIENAIME JEAN JACQUESDirectorFeb 09 '24Sale88.2815,0001,324,200419,602Feb 12 05:20 PM
BIENAIME JEAN JACQUESDirectorFeb 08 '24Option Exercise63.1015,000946,500434,602Feb 12 05:20 PM
BIENAIME JEAN JACQUESDirectorFeb 08 '24Sale89.7715,0001,346,550419,602Feb 12 05:20 PM
BIENAIME JEAN JACQUESDirectorJan 10 '24Option Exercise63.1010,000631,000435,162Jan 11 02:40 PM
BIENAIME JEAN JACQUESDirectorJan 10 '24Sale96.3810,000963,800425,162Jan 11 02:40 PM
BIENAIME JEAN JACQUESDirectorJan 09 '24Option Exercise63.1010,000631,000435,162Jan 11 02:40 PM
BIENAIME JEAN JACQUESDirectorJan 09 '24Sale98.1910,000981,900425,162Jan 11 02:40 PM
BIENAIME JEAN JACQUESDirectorDec 21 '23Option Exercise63.1010,000631,000435,112Dec 22 05:14 PM
BIENAIME JEAN JACQUESDirectorDec 21 '23Sale93.9910,000939,900425,112Dec 22 05:14 PM
Davis George EricEVP, Chief Legal OfficerDec 13 '23Sale95.3013,7641,311,70955,710Dec 14 06:18 PM
Ajer Jeffrey RobertEVP, Chief Commercial OfficerAug 16 '23Sale90.005,000450,00060,804Aug 17 03:57 PM
FUCHS HENRY JPresident, Worldwide R&DAug 10 '23Sale90.4312,0001,085,111176,187Aug 11 01:59 PM
Guyer Charles GregEVP, Chief Technical OfficerAug 09 '23Sale93.305,360500,10940,041Aug 10 04:47 PM
Davis George EricEVP, Chief Legal OfficerAug 08 '23Sale89.4211,000983,66269,474Aug 09 07:08 PM
BIENAIME JEAN JACQUESChief Executive OfficerAug 08 '23Sale88.296,000529,740422,732Aug 09 07:05 PM
BIENAIME JEAN JACQUESChief Executive OfficerAug 07 '23Sale88.104,000352,400428,732Aug 09 07:05 PM
BIENAIME JEAN JACQUESChief Executive OfficerMay 12 '23Option Exercise67.8146,5003,153,165472,713May 16 05:22 PM
MEIER RICHARD ADirectorMay 12 '23Option Exercise67.818,500576,385117,494May 17 06:14 PM
HERON ELAINE JDirectorMay 12 '23Option Exercise67.818,500576,38594,068May 17 06:14 PM
BIENAIME JEAN JACQUESChief Executive OfficerMay 11 '23Option Exercise67.8130,0002,034,300456,213May 15 04:58 PM
BIENAIME JEAN JACQUESChief Executive OfficerMay 11 '23Sale94.6730,0002,840,226426,213May 15 04:58 PM
BIENAIME JEAN JACQUESChief Executive OfficerMay 10 '23Option Exercise67.8130,0002,034,300456,213May 11 05:04 PM
BIENAIME JEAN JACQUESChief Executive OfficerMay 10 '23Sale94.8530,0002,845,397426,213May 11 05:04 PM
BIENAIME JEAN JACQUESChief Executive OfficerMay 09 '23Option Exercise67.8130,0002,034,300456,213May 11 05:04 PM
BIENAIME JEAN JACQUESChief Executive OfficerMay 09 '23Sale94.9330,0002,847,973426,213May 11 05:04 PM
BIENAIME JEAN JACQUESChief Executive OfficerApr 10 '23Option Exercise67.8110,000678,100435,896Apr 12 04:08 PM
BIENAIME JEAN JACQUESChief Executive OfficerApr 10 '23Sale99.5610,000995,600425,896Apr 12 04:08 PM
BIENAIME JEAN JACQUESChief Executive OfficerApr 06 '23Option Exercise67.8110,000678,100435,896Apr 10 07:00 PM
BIENAIME JEAN JACQUESChief Executive OfficerApr 06 '23Sale96.1310,000961,300425,896Apr 10 07:00 PM
LAWLIS V BRYANDirectorApr 03 '23Option Exercise67.818,500576,38537,450Apr 04 07:59 PM
LAWLIS V BRYANDirectorApr 03 '23Sale97.098,500825,26528,950Apr 04 07:59 PM
Last Close
Mar 28 04:00PM ET
229.72
Dollar change
-13.55
Percentage change
-5.57
%
UTHR United Therapeutics Corp daily Stock Chart
Index- P/E11.58 EPS (ttm)19.84 Insider Own7.84% Shs Outstand47.04M Perf Week-3.04%
Market Cap10.81B Forward P/E9.43 EPS next Y24.37 Insider Trans-7.15% Shs Float43.37M Perf Month1.07%
Income984.80M PEG1.19 EPS next Q5.79 Inst Own94.72% Short Float4.42% Perf Quarter6.91%
Sales2.33B P/S4.64 EPS this Y18.78% Inst Trans1.05% Short Ratio4.72 Perf Half Y-1.18%
Book/sh127.23 P/B1.81 EPS next Y3.56% ROA14.81% Short Interest1.92M Perf Year4.93%
Cash/sh63.62 P/C3.61 EPS next 5Y9.70% ROE18.27% 52W Range204.44 - 261.54 Perf YTD4.47%
Dividend Est.- P/FCF14.46 EPS past 5Y8.15% ROI15.67% 52W High-12.17% Beta0.53
Dividend TTM- Quick Ratio4.28 Sales past 5Y8.02% Gross Margin88.94% 52W Low12.37% ATR (14)7.56
Dividend Ex-Date- Current Ratio4.41 EPS Y/Y TTM31.54% Oper. Margin50.91% RSI (14)45.20 Volatility4.19% 3.18%
Employees1168 Debt/Eq0.12 Sales Y/Y TTM20.20% Profit Margin42.31% Recom1.56 Target Price291.75
Option/ShortYes / Yes LT Debt/Eq0.05 EPS Q/Q63.02% Payout0.00% Rel Volume2.74 Prev Close243.27
Sales Surprise6.90% EPS Surprise1.76% Sales Q/Q25.07% EarningsFeb 21 BMO Avg Volume406.62K Price229.72
SMA20-3.64% SMA501.78% SMA2000.54% Trades Volume1,114,533 Change-5.57%
Date Action Analyst Rating Change Price Target Change
Feb-12-24Upgrade Goldman Sell → Neutral $213 → $215
Feb-05-24Initiated Leerink Partners Outperform $330
Dec-08-23Initiated Wells Fargo Overweight $309
Dec-06-22Initiated UBS Buy $320
Dec-05-22Initiated Goldman Sell $230
Oct-11-22Initiated Morgan Stanley Overweight $288
Sep-20-22Reiterated BofA Securities Underperform
Sep-19-22Resumed Wedbush Outperform $263
Feb-11-22Initiated BTIG Research Neutral
Jul-14-21Upgrade Argus Hold → Buy $205
Mar-27-24 07:00PM
Mar-26-24 10:00AM
07:00AM
Mar-25-24 07:00PM
07:00AM
09:04PM Loading…
Mar-22-24 09:04PM
11:30AM
Mar-21-24 07:01PM
Mar-17-24 08:50AM
Mar-16-24 02:42PM
Mar-13-24 10:54PM
03:12PM
Mar-11-24 07:01PM
Mar-09-24 01:09PM
Mar-08-24 03:01AM
06:28AM Loading…
Mar-05-24 06:28AM
06:00AM
Feb-27-24 06:00AM
Feb-26-24 07:31PM
03:20PM
Feb-23-24 05:40AM
Feb-22-24 12:22PM
09:55AM
09:54AM
09:45AM
01:16AM
12:03AM
Feb-21-24 03:17PM
09:30AM
06:51AM
06:31AM Loading…
06:31AM
06:24AM
06:15AM
06:14AM
06:04AM
06:00AM
05:55AM
Feb-20-24 08:48AM
Feb-19-24 09:15AM
Feb-15-24 11:35PM
Feb-14-24 06:00AM
01:51AM
Feb-07-24 12:10PM
Feb-05-24 10:10AM
Feb-02-24 09:10PM
Jan-25-24 08:32AM
Jan-22-24 05:27PM
Jan-18-24 07:58PM
Jan-16-24 03:57PM
Jan-06-24 07:01AM
Jan-01-24 09:45AM
Dec-29-23 06:00AM
Dec-24-23 05:34PM
Dec-22-23 07:01AM
Dec-19-23 01:01PM
Dec-15-23 09:50AM
05:06AM
Dec-13-23 09:15AM
Dec-12-23 06:00AM
Dec-11-23 09:45AM
Dec-08-23 09:05AM
03:27AM
Dec-07-23 06:00AM
Dec-06-23 09:18PM
Dec-01-23 11:31AM
Nov-24-23 09:50AM
Nov-18-23 07:03AM
Nov-14-23 04:05PM
Nov-13-23 09:50PM
Nov-09-23 11:12AM
03:49AM
Nov-08-23 12:30PM
Nov-06-23 12:19AM
Nov-03-23 11:43PM
Nov-02-23 02:34PM
01:15PM
Nov-01-23 11:00PM
09:35AM
09:30AM
09:21AM
07:15AM
06:04AM
06:00AM
Oct-31-23 06:05AM
06:00AM
Oct-30-23 06:05AM
Oct-26-23 10:02AM
Oct-25-23 10:02AM
06:00AM
Oct-20-23 09:55PM
Oct-17-23 09:50AM
Oct-02-23 11:34AM
Sep-28-23 10:56AM
Sep-22-23 11:01PM
02:15PM
Sep-20-23 04:15PM
Sep-12-23 06:00AM
Sep-09-23 01:03AM
Sep-01-23 06:00AM
Aug-20-23 10:00AM
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 26 '24Option Exercise129.4915,0001,942,35015,130Mar 27 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 26 '24Sale248.3315,0003,724,939130Mar 27 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 25 '24Option Exercise129.4915,0001,942,35015,130Mar 27 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 25 '24Sale243.3615,0003,650,401130Mar 27 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 22 '24Option Exercise129.4915,0001,942,35015,130Mar 25 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 22 '24Sale237.0515,0003,555,823130Mar 25 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 21 '24Option Exercise129.4915,0001,942,35015,130Mar 25 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELMar 21 '24Option Exercise117.766,000706,56042,710Mar 22 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 21 '24Sale236.3415,0003,545,158130Mar 25 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELMar 21 '24Sale236.456,0001,418,72636,710Mar 22 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 20 '24Option Exercise129.4915,0001,942,35015,130Mar 21 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 20 '24Sale235.9515,0003,539,273130Mar 21 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 19 '24Option Exercise129.4915,0001,942,35015,130Mar 21 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 19 '24Sale236.5915,0003,548,922130Mar 21 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 14 '24Option Exercise129.4915,0001,942,35015,130Mar 15 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 14 '24Sale237.8215,0003,567,243130Mar 15 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 13 '24Option Exercise129.4915,0001,942,35015,130Mar 15 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 13 '24Sale242.8015,0003,641,949130Mar 15 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 12 '24Option Exercise129.4915,0001,942,35015,130Mar 13 04:30 PM
Olian Judy D.DirectorMar 12 '24Option Exercise175.435,000877,15012,305Mar 13 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 12 '24Sale247.9515,0003,719,247130Mar 13 04:30 PM
Olian Judy D.DirectorMar 12 '24Sale248.205,0001,241,0067,305Mar 13 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 11 '24Option Exercise129.4915,0001,942,35015,130Mar 13 04:30 PM
Thompson Tommy GDirectorMar 11 '24Option Exercise88.035,000440,15013,480Mar 12 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 11 '24Sale248.0015,0003,720,056130Mar 13 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 08 '24Option Exercise129.4915,0001,942,35015,130Mar 11 04:30 PM
Klein Katherine JDirectorMar 08 '24Option Exercise123.759,7911,211,63613,431Mar 11 04:30 PM
Thompson Tommy GDirectorMar 08 '24Option Exercise88.032,000176,06010,480Mar 11 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 08 '24Sale241.8415,0003,627,607130Mar 11 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 07 '24Option Exercise129.4915,0001,942,35015,130Mar 11 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELMar 07 '24Option Exercise117.766,000706,56042,599Mar 07 04:52 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 07 '24Sale240.3115,0003,604,633130Mar 11 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELMar 07 '24Sale237.386,0001,424,30936,599Mar 07 04:52 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 06 '24Option Exercise129.4915,0001,942,35015,130Mar 07 04:30 PM
Giltner RichardDirectorMar 06 '24Option Exercise88.0310,000880,30025,620Mar 07 04:30 PM
Thompson Tommy GDirectorMar 06 '24Option Exercise88.032,000176,06010,480Mar 07 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 06 '24Sale236.2515,0003,543,793130Mar 07 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 05 '24Option Exercise129.496,300815,7876,430Mar 07 04:30 PM
ROTHBLATT MARTINE ACHAIRPERSON & CEOMar 05 '24Sale230.936,3001,454,886130Mar 07 04:30 PM
Thompson Tommy GDirectorMar 01 '24Option Exercise88.032,000176,06010,480Mar 04 04:33 PM
KURZWEIL RAYDirectorFeb 23 '24Option Exercise88.0315,0001,320,45026,180Feb 26 04:30 PM
Thompson Tommy GDirectorFeb 23 '24Option Exercise88.032,000176,06010,480Feb 26 04:30 PM
PATUSKY CHRISTOPHERDirectorFeb 23 '24Sale224.001,680376,3204Feb 26 04:31 PM
MAHON PAUL AEVP & GENERAL COUNSELFeb 15 '24Option Exercise117.766,000706,56042,599Feb 15 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELFeb 15 '24Sale215.316,0001,291,88536,599Feb 15 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELFeb 01 '24Option Exercise117.766,000706,56042,599Feb 02 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELFeb 01 '24Sale215.016,0001,290,08336,599Feb 02 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELJan 18 '24Option Exercise117.766,000706,56042,599Jan 18 05:56 PM
MAHON PAUL AEVP & GENERAL COUNSELJan 18 '24Sale218.726,0001,312,32236,599Jan 18 05:56 PM
MAHON PAUL AEVP & GENERAL COUNSELJan 04 '24Option Exercise117.766,000706,56042,599Jan 05 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELJan 04 '24Sale227.976,0001,367,79836,599Jan 05 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELDec 21 '23Option Exercise117.766,000706,56042,599Dec 26 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELDec 21 '23Sale229.276,0001,375,60536,599Dec 26 04:30 PM
Mesa NildaDirectorDec 19 '23Sale244.90605148,1645,698Dec 20 04:30 PM
CAUSEY CHRISTOPHERDirectorDec 15 '23Sale255.00400102,0004,185Dec 18 04:30 PM
CAUSEY CHRISTOPHERDirectorDec 12 '23Option Exercise175.433,000526,2907,585Dec 13 05:29 PM
CAUSEY CHRISTOPHERDirectorDec 12 '23Sale249.683,000749,0344,585Dec 13 05:29 PM
MAHON PAUL AEVP & GENERAL COUNSELDec 07 '23Option Exercise117.766,000706,56042,599Dec 07 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELDec 07 '23Sale238.896,0001,433,33136,599Dec 07 04:30 PM
Giltner RichardDirectorDec 01 '23Option Exercise88.035,000440,15020,620Dec 04 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELNov 16 '23Option Exercise117.766,000706,56042,599Nov 17 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELNov 16 '23Sale226.606,0001,359,59336,599Nov 17 04:30 PM
PATUSKY CHRISTOPHERDirectorNov 07 '23Option Exercise88.032,000176,0603,684Nov 08 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELNov 02 '23Option Exercise117.766,000706,56042,599Nov 03 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELNov 02 '23Sale225.766,0001,354,55436,599Nov 03 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELOct 19 '23Option Exercise117.766,000706,56042,599Oct 20 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELOct 19 '23Sale225.436,0001,352,59136,599Oct 20 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELOct 05 '23Option Exercise117.766,000706,56042,599Oct 10 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELOct 05 '23Sale223.826,0001,342,92336,599Oct 10 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELSep 21 '23Option Exercise117.766,000706,56042,599Sep 22 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELSep 21 '23Sale222.196,0001,333,15036,599Sep 22 04:30 PM
Mesa NildaDirectorSep 13 '23Sale222.3638385,1646,303Sep 15 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELSep 07 '23Option Exercise117.766,000706,56042,599Sep 08 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELSep 07 '23Sale222.986,0001,337,90536,599Sep 08 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELAug 17 '23Option Exercise117.766,000706,56042,599Aug 18 04:30 PM
PATUSKY CHRISTOPHERDirectorAug 17 '23Option Exercise88.032,000176,0603,684Aug 18 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELAug 17 '23Sale229.546,0001,377,26536,599Aug 18 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELAug 03 '23Option Exercise117.766,000706,56042,599Aug 04 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELAug 03 '23Sale236.256,0001,417,47036,599Aug 04 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELJul 20 '23Option Exercise120.262,500300,65039,099Jul 24 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELJul 20 '23Sale243.872,500609,67536,599Jul 24 04:30 PM
SULLIVAN LOUIS WDirectorJul 07 '23Option Exercise0.00880013,060Jul 07 04:30 PM
Thompson Tommy GDirectorJul 07 '23Option Exercise0.0088008,480Jul 07 04:30 PM
Olian Judy D.DirectorJul 07 '23Option Exercise0.001,75008,255Jul 07 04:30 PM
Mesa NildaDirectorJul 07 '23Option Exercise0.0088006,686Jul 07 04:30 PM
KURZWEIL RAYDirectorJul 07 '23Option Exercise0.00880011,180Jul 07 04:30 PM
Klein Katherine JDirectorJul 07 '23Option Exercise0.0088003,640Jul 07 04:30 PM
DWEK RAYMONDDirectorJul 07 '23Option Exercise0.001,75001,750Jul 07 04:30 PM
Giltner RichardDirectorJul 07 '23Option Exercise0.001,750015,620Jul 07 04:30 PM
CAUSEY CHRISTOPHERDirectorJul 07 '23Option Exercise0.001,75004,585Jul 07 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELJul 06 '23Option Exercise120.266,000721,56042,599Jul 07 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELJul 06 '23Sale215.196,0001,291,16536,599Jul 07 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELJun 15 '23Option Exercise120.266,000721,56042,599Jun 15 05:23 PM
MAHON PAUL AEVP & GENERAL COUNSELJun 15 '23Sale227.776,0001,366,63436,599Jun 15 05:23 PM
Thompson Tommy GDirectorJun 13 '23Option Exercise88.031,00088,0308,600Jun 14 04:30 PM
Thompson Tommy GDirectorJun 02 '23Option Exercise88.031,00088,0308,600Jun 05 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELJun 01 '23Option Exercise120.266,000721,56042,599Jun 01 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELJun 01 '23Sale209.116,0001,254,67736,599Jun 01 04:30 PM
Giltner RichardDirectorMay 22 '23Option Exercise63.905,000319,50018,870May 23 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELMay 18 '23Option Exercise120.266,000721,56042,599May 18 04:30 PM